Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

NCT00087516 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

741

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Sitagliptin (MK0431)
DRUG: Sitagliptin
DRUG: Placebo
DRUG: Placebo
DRUG: Metformin - Rescue

Sponsor

Merck Sharp & Dohme LLC